Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 249

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

A PD‐1 polymorphism is associated with disease progression in multiple sclerosis

Kroner, Antje, Mehling, Matthias, Hemmer, Bernhard, Rieckmann, Peter, Toyka, Klaus V., Mäurer, Mathias, Wiendl, Heinz·2005·Annals of Neurology

Abstract

T cells are considered to play a pivotal role in orchestrating the self‐reactive immune responses in multiple sclerosis (MS). Programmed death 1 (PD‐1) is a member of the B7/CD28 superfamily of costimulatory molecules exerting inhibitory functions on T cells. Recently, an intronic 7146G/A polymorphism within the PD‐1 gene was described and suggested to be associated with autoimmunity. We investigated whether this genetic polymorphism is a genetic modifier for risk and progression of MS. Blood samples from 939 German MS patients (mean age, 39 years; range, 13–71; 566 patients [60%] with relapsing‐remitting MS, 279 (30%) with secondary, and 94 (10%) with primary progressive MS) and 272 healthy white controls were tested. Genotyping was performed by polymerase chain reaction and restriction enzyme digestion; results were confirmed by automatic sequencing. A significant association of the mutated allele with a progressive disease course was detected (44% 7146G vs 56% 7146A, χ 2 p = 0.002). Consequences of the PD‐1 mutation for T‐cell function were assessed ex vivo in some patients using microsphere‐stimulated peripheral blood lymphocytes and purified CD4 cells. Importantly, PD‐1–mediated inhibition of T‐cell cytokine secretion (interferon‐γ) is impaired in patients carrying the PD‐1 polymorphism. In conclusion, our data suggest that PD‐1 polymorphism is a genetic modifier of the progression of MS, possibly through inducing a partial defect in PD‐1–mediated inhibition of T‐cell activation. Ann Neurol 2005

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.20514

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 249

Metadata

Authors
Kroner, A., Mehling, M., Hemmer, B., Rieckmann, P., Toyka, K. V., Mäurer, M., & Wiendl, H.
Venue
Annals of Neurology
Publisher
Wiley
Published
2005-05-23
Volume
58
Issue
1
Pages
50-57
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2083340623
Cited by
249
References
4
FWCI
7.70
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A PD‐1 polymorphism is associated with disease progression in multiple sclerosis. https://app.cochat.ai/papers/10.1002/ana.20514
The paper
Kroner, A., Mehling, M., Hemmer, B., Rieckmann, P., Toyka, K. V., Mäurer, M., & Wiendl, H. (2005). A PD‐1 polymorphism is associated with disease progression in multiple sclerosis. Annals of Neurology. https://doi.org/10.1002/ana.20514

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.